What they found: Plasma NAD+ did not rise directly , it was rapidly metabolized Plasma nicotinamide and methyl-nicotinamide rose markedly , markers of NAD+ metabolism NAD+ likely reaches tissues as its metabolites (not as whole NAD+) Clinically, patients subjectively reported increased energy during and after the infusion No serious adverse events during the 6-hour IV infusion Why it matters: The study provides rare clinical data on IV NAD+ , the administration route used by NAD+ clinics off-label
The chart below shows exact injection volumes for various doses
Interestingly, Lavi and colleagues 40 , through a mathematical model, showed how cancer cell density and cells alteration rate impact the heterogeneity over time, and its consequences on multidrug resistance
Additionally, in rare cases, individuals with specific genetic variations in flavin metabolism might actually experience an increase in sulfite levels with riboflavin supplementation
When your provider has the full picture, they tailor your IV infusion and monitor you more closely to prevent complications
